JPWO2022220227A1 - - Google Patents
Info
- Publication number
- JPWO2022220227A1 JPWO2022220227A1 JP2023514646A JP2023514646A JPWO2022220227A1 JP WO2022220227 A1 JPWO2022220227 A1 JP WO2022220227A1 JP 2023514646 A JP2023514646 A JP 2023514646A JP 2023514646 A JP2023514646 A JP 2023514646A JP WO2022220227 A1 JPWO2022220227 A1 JP WO2022220227A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021068414 | 2021-04-14 | ||
| PCT/JP2022/017548 WO2022220227A1 (en) | 2021-04-14 | 2022-04-12 | Tetrahydropyridopyrimidine compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022220227A1 true JPWO2022220227A1 (en) | 2022-10-20 |
Family
ID=83640095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514646A Pending JPWO2022220227A1 (en) | 2021-04-14 | 2022-04-12 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2022220227A1 (en) |
| TW (1) | TW202304908A (en) |
| WO (1) | WO2022220227A1 (en) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME01832B (en) * | 2006-12-29 | 2014-12-20 | Rigel Pharmaceuticals Inc | Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| ES2537480T3 (en) * | 2008-07-09 | 2015-06-08 | Rigel Pharmaceuticals, Inc. | Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| US8546433B2 (en) * | 2009-01-16 | 2013-10-01 | Rigel Pharmaceuticals, Inc. | Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer |
| WO2012135800A1 (en) * | 2011-04-01 | 2012-10-04 | University Of Utah Research Foundation | Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase |
| SG10201510307WA (en) * | 2011-11-14 | 2016-01-28 | Cephalon Inc | Uracil derivatives as axl and c-met kinase inhibitors |
| PL2810937T3 (en) * | 2012-01-31 | 2017-07-31 | Daiichi Sankyo Company, Limited | Pyridone derivative |
| TWI649308B (en) * | 2013-07-24 | 2019-02-01 | 小野藥品工業股份有限公司 | Quinoline derivative |
| ES2788390T3 (en) * | 2014-02-04 | 2020-10-21 | Astellas Pharma Inc | Medical composition comprising a heterocyclic diamino-carboxamide compound as active ingredient |
| TWI723572B (en) * | 2014-07-07 | 2021-04-01 | 日商第一三共股份有限公司 | Pyridone derivatives containing tetrahydropyranylmethyl group and use thereof |
| ES2746839T3 (en) * | 2014-12-18 | 2020-03-09 | Pfizer | Pyrimidine and triazine derivatives and their use as AXL inhibitors |
-
2022
- 2022-04-12 WO PCT/JP2022/017548 patent/WO2022220227A1/en active Application Filing
- 2022-04-12 TW TW111113796A patent/TW202304908A/en unknown
- 2022-04-12 JP JP2023514646A patent/JPWO2022220227A1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202304908A (en) | 2023-02-01 |
| WO2022220227A1 (en) | 2022-10-20 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230517 |